NCT05840692View on ClinicalTrials.gov

The Effect of Escitalopram in PCOS

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

Escitalopram 20 mg

Antidepressant

DRUG

Placebo

Trial Locations (1)

5000

Odense Universitetshospital, Odense

All Listed Sponsors
lead

Odense University Hospital

OTHER

NCT05840692 - The Effect of Escitalopram in PCOS | Biotech Hunter | Biotech Hunter